|
Volumn 27, Issue 6, 2001, Pages 688-694
|
Management of diabetic foot lesions in hospital: Costs and benefits
a a a a a a |
Author keywords
Amputation; Costs; Diabetes mellitus; Foot lesion
|
Indexed keywords
AMPICILLIN;
ANTIBIOTIC AGENT;
GENTAMICIN;
INSULIN;
METRONIDAZOLE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXACILLIN;
ADULT;
ARTICLE;
CLINICAL EXAMINATION;
COST BENEFIT ANALYSIS;
DEVELOPING COUNTRY;
DIABETES MELLITUS;
DIABETIC FOOT;
DISEASE CLASSIFICATION;
ENDOCRINOLOGY;
FEMALE;
FOOT AMPUTATION;
FOOT ULCER;
GENERAL PRACTITIONER;
HOSPITAL CARE;
HOSPITAL COST;
HOSPITAL DEPARTMENT;
HOSPITAL PATIENT;
HOSPITALIZATION;
HUMAN;
LABORATORY TEST;
LENGTH OF STAY;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL SPECIALIST;
PATIENT EDUCATION;
SHOE;
ULCER HEALING;
AMPUTATION;
COST-BENEFIT ANALYSIS;
DIABETIC FOOT;
FEMALE;
HEALTH CARE COSTS;
HOSPITALIZATION;
HUMANS;
LENGTH OF STAY;
MALE;
|
EID: 0035661548
PISSN: 12623636
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (21)
|
References (34)
|